MAPT and Alzheimer disease: Additionally, tau often co-localizes and interacts with TDP-43 pathology, particularly in LATE-NC and other AD cases (Nelson et al., 2019; Tomé et al., 2020; Youssef et al., 2025), complicating the attribution of neurodegeneration solely to tau.